Please Wait
Applying Filters...
menu
    • menu

    FDA Orange Book

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Xls

    CATEGORY PAGE
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3SCIEGEN PHARMS

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    price-trend Ask Us

    01

    Brand Name : OLMESARTAN MEDOXOMIL

    BePharma
    Not Confirmed
    arrow

    Brand Name : OLMESARTAN MEDOXOMIL

    BePharma
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    OLMESARTAN MEDOXOMIL

    Dosage Form : TABLET; ORAL

    Proprietary Name : OLMESARTAN MEDOXOMIL

    Dosage Strength : 40MG

    Approval Date : 2018-06-29

    Application Number : 208130

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : OLMESARTAN MEDOXOMIL

    BePharma
    Not Confirmed
    arrow

    Brand Name : OLMESARTAN MEDOXOMIL

    BePharma
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    OLMESARTAN MEDOXOMIL

    Dosage Form : TABLET; ORAL

    Proprietary Name : OLMESARTAN MEDOXOMIL

    Dosage Strength : 5MG

    Approval Date : 2018-06-29

    Application Number : 208130

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : OLMESARTAN MEDOXOMIL

    BePharma
    Not Confirmed
    arrow

    Brand Name : OLMESARTAN MEDOXOMIL

    BePharma
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    OLMESARTAN MEDOXOMIL

    Dosage Form : TABLET; ORAL

    Proprietary Name : OLMESARTAN MEDOXOMIL

    Dosage Strength : 20MG

    Approval Date : 2018-06-29

    Application Number : 208130

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.